All
- All
- Company News
- Press Releases
Farewell to 2023, and WE are Sailing forward to 2024
Farewell to 2023, and WE are Sailing forward to 2024 Year-end Review for 2023 Throughout 2023, despite myriad challenges, Porton stood united, striving, and collaborating...
The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia.
The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in...
The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in the industry and academia.
The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in the...
Porton Gets Improved in the 2023 S&P Global ESG Score
Porton Pharma Solutions Ltd. is glad to announce that it scored 38 (out of 100) in the 2023 S&P Global Corporate Sustainability Assessment reflecting an...
Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization and Drug Product Development Services
Porton Pharma Solutions has just opened its new drug development facility in Cranbury, New Jersey, operated under its US subsidiary J-Star Research. With over 40,000...
Pharma Digital Intelligence Summit will be held on 5th, September, 2023
Background In order to thoroughly implement General Secretary Xi Jinping’s important exposition on the development of digital economy, his spirit of sending congratulatory letters to...
J-STAR Research, Inc.’s Cranbury Open House
Join us for a Journey of Innovation at J-STAR Research, Inc.'s Cranbury Open House! 🗓 September 6th & 7th, 4 PM - 6 PM 📍...
[Important Notice] Porton Announcement Regarding the Change of Email Domain
Dear valued customers and partners, We would like to extend our gratitude for your continuous support towards Porton Pharma Solutions Ltd. In order to further...
Porton Pharma Solutions Expands Global Reach with New Site in Slovenia and Enhanced Manufacturing Capabilities
Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art...
Porton Pharma Solutions Welcomes Alexandra Pichard Nielsen, VP of Business Development, at BOS Basel 2023, Driving Innovation and Growth in the Pharmaceutical Industry
We’re honored to have Alexandra Pichard Nielsen, Vice President for Business Development at Porton Pharma Solutions Ltd., join us at BOS Basel 2023! We are...
Porton Pharma Solutions Welcomes Dr. Wenfang Miao as CEO of J-STAR Research, Ushering in a New Era of Pharmaceutical Innovation
Join us in welcoming Dr. Wenfang Miao (Renee) as the new CEO of Porton USA, L.L.C. and J-STAR Research, Inc., and Vice-President of Porton Pharma...
Porton Pharma Solutions Launches State-of-the-Art Small Molecule Platform in Shanghai, Elevating CDMO Services
We are thrilled to announce the establishment of our state-of-the-art Small Molecule Platform in Shanghai, revolutionizing our CDMO services. With this exciting development, Porton Pharma Solutions...
